The cardiovascular system medicine sales in Chile have demonstrated fluctuations over the past years, showcasing periods of both growth and decline. In 2023, the sales value reached $251.1 million, with a year-on-year increase of 2.74%. The Compound Annual Growth Rate (CAGR) over the last five years was 0.79%, indicating a relatively slow average annual growth. From 2019 to 2021, the market faced contractions, but this was followed by a recovery in 2022 and 2023, showing signs of stabilization and modest growth.

Future trends to watch for include:

Influence of economic factors on the healthcare budget.
Advancements in cardiovascular treatments and their market adoption.
Potential policy changes in Chile's healthcare system affecting drug pricing and availability.
Population aging leading to a higher prevalence of cardiovascular diseases.
Impact of global supply chain changes post-pandemic on the pharmaceutical market.